Literature DB >> 29180445

Flipping the cyclooxygenase (Ptgs) genes reveals isoform-specific compensatory functions.

Xinzhi Li1, Liudmila L Mazaleuskaya2, Chong Yuan3, Laurel L Ballantyne1, Hu Meng2, William L Smith3, Garret A FitzGerald2, Colin D Funk4.   

Abstract

Two prostaglandin (PG) H synthases encoded by Ptgs genes, colloquially known as cyclooxygenase (COX)-1 and COX-2, catalyze the formation of PG endoperoxide H2, the precursor of the major prostanoids. To address the functional interchangeability of these two isoforms and their distinct roles, we have generated COX-2>COX-1 mice whereby Ptgs2 is knocked in to the Ptgs1 locus. We then "flipped" Ptgs genes to successfully create the Reversa mouse strain, where knock-in COX-2 is expressed constitutively and knock-in COX-1 is lipopolysaccharide (LPS) inducible. In macrophages, flipping the two Ptgs genes has no obvious impact on COX protein subcellular localization. COX-1 was shown to compensate for PG synthesis at high concentrations of substrate, whereas elevated LPS-induced PG production was only observed for cells expressing endogenous COX-2. Differential tissue-specific patterns of expression of the knock-in proteins were evident. Thus, platelets from COX-2>COX-1 and Reversa mice failed to express knock-in COX-2 and, therefore, thromboxane (Tx) production in vitro and urinary Tx metabolite formation in COX-2>COX-1 and Reversa mice in vivo were substantially decreased relative to WT and COX-1>COX-2 mice. Manipulation of COXs revealed isoform-specific compensatory functions and variable degrees of interchangeability for PG biosynthesis in cells/tissues.
Copyright © 2018 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  animal model; eicosanoid; gene targeting; macrophage; platelet; prostaglandin

Mesh:

Substances:

Year:  2017        PMID: 29180445      PMCID: PMC5748500          DOI: 10.1194/jlr.M079996

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  59 in total

Review 1.  Cyclooxygenases: structural, cellular, and molecular biology.

Authors:  W L Smith; D L DeWitt; R M Garavito
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

2.  Targeted cyclooxygenase gene (ptgs) exchange reveals discriminant isoform functionality.

Authors:  Ying Yu; Jinjin Fan; Yiqun Hui; Carol A Rouzer; Lawrence J Marnett; Andres J Klein-Szanto; Garret A FitzGerald; Colin D Funk
Journal:  J Biol Chem       Date:  2006-11-16       Impact factor: 5.157

3.  Genomic and lipidomic analyses differentiate the compensatory roles of two COX isoforms during systemic inflammation in mice.

Authors:  Xinzhi Li; Liudmila L Mazaleuskaya; Laurel L Ballantyne; Hu Meng; Garret A FitzGerald; Colin D Funk
Journal:  J Lipid Res       Date:  2017-11-27       Impact factor: 5.922

4.  Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents.

Authors:  R G Kurumbail; A M Stevens; J K Gierse; J J McDonald; R A Stegeman; J Y Pak; D Gildehaus; J M Miyashiro; T D Penning; K Seibert; P C Isakson; W C Stallings
Journal:  Nature       Date:  1996 Dec 19-26       Impact factor: 49.962

5.  A selective cysteinyl leukotriene receptor 2 antagonist blocks myocardial ischemia/reperfusion injury and vascular permeability in mice.

Authors:  Nathan C Ni; Dong Yan; Laurel L Ballantyne; Alma Barajas-Espinosa; Tim St Amand; Derek A Pratt; Colin D Funk
Journal:  J Pharmacol Exp Ther       Date:  2011-09-08       Impact factor: 4.030

6.  Human cyclooxygenase-2 is a sequence homodimer that functions as a conformational heterodimer.

Authors:  Liang Dong; Alex J Vecchio; Narayan P Sharma; Brice J Jurban; Michael G Malkowski; William L Smith
Journal:  J Biol Chem       Date:  2011-04-05       Impact factor: 5.157

7.  The tissue-specific, compensatory expression of cyclooxygenase-1 and -2 in transgenic mice.

Authors:  Jianyi Zhang; Sarita Goorha; Rajendra Raghow; Leslie R Ballou
Journal:  Prostaglandins Other Lipid Mediat       Date:  2002-02       Impact factor: 3.072

8.  Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype.

Authors:  D W Threadgill; A A Dlugosz; L A Hansen; T Tennenbaum; U Lichti; D Yee; C LaMantia; T Mourton; K Herrup; R C Harris
Journal:  Science       Date:  1995-07-14       Impact factor: 47.728

9.  Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration.

Authors:  R Langenbach; S G Morham; H F Tiano; C D Loftin; B I Ghanayem; P C Chulada; J F Mahler; C A Lee; E H Goulding; K D Kluckman; H S Kim; O Smithies
Journal:  Cell       Date:  1995-11-03       Impact factor: 41.582

Review 10.  Oxidative metabolism of endocannabinoids by COX-2.

Authors:  Kevin R Kozak; Jeffery J Prusakiewicz; Lawrence J Marnett
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

View more
  9 in total

1.  Genomic and lipidomic analyses differentiate the compensatory roles of two COX isoforms during systemic inflammation in mice.

Authors:  Xinzhi Li; Liudmila L Mazaleuskaya; Laurel L Ballantyne; Hu Meng; Garret A FitzGerald; Colin D Funk
Journal:  J Lipid Res       Date:  2017-11-27       Impact factor: 5.922

2.  Perivascular adipose tissue-derived extracellular vesicle miR-221-3p mediates vascular remodeling.

Authors:  Xinzhi Li; Laurel L Ballantyne; Ying Yu; Colin D Funk
Journal:  FASEB J       Date:  2019-08-30       Impact factor: 5.191

Review 3.  Interactions of fatty acids, nonsteroidal anti-inflammatory drugs, and coxibs with the catalytic and allosteric subunits of cyclooxygenases-1 and -2.

Authors:  William L Smith; Michael G Malkowski
Journal:  J Biol Chem       Date:  2019-02-01       Impact factor: 5.157

4.  Differential compensation of two cyclooxygenases in renal homeostasis is independent of prostaglandin-synthetic capacity under basal conditions.

Authors:  Xinzhi Li; Liudmila L Mazaleuskaya; Laurel L Ballantyne; Hu Meng; Garret A FitzGerald; Colin D Funk
Journal:  FASEB J       Date:  2018-04-20       Impact factor: 5.191

5.  Increased COX-1 expression in benign prostate epithelial cells is triggered by mitochondrial dysfunction.

Authors:  Chandler N Hudson; Kai He; Laura E Pascal; Teresa Liu; Livianna K Myklebust; Rajiv Dhir; Pooja Srivastava; Naoki Yoshimura; Zhou Wang; William A Ricke; Donald B DeFranco
Journal:  Am J Clin Exp Urol       Date:  2022-08-15

6.  Synthesis and Different Effects of Biotinylated PAMAM G3 Dendrimer Substituted with Nimesulide in Human Normal Fibroblasts and Squamous Carcinoma Cells.

Authors:  Łukasz Uram; Aleksandra Filipowicz-Rachwał; Maria Misiorek; Aleksandra Winiarz; Elżbieta Wałajtys-Rode; Stanisław Wołowiec
Journal:  Biomolecules       Date:  2019-09-01

7.  Signaling Pathways Mediating Bradykinin-Induced Contraction in Murine and Human Detrusor Muscle.

Authors:  Kinga Borsodi; Helga Balla; Péter József Molnár; Ádám Lénárt; István Kenessey; András Horváth; Attila Keszthelyi; Miklós Romics; Attila Majoros; Péter Nyirády; Stefan Offermanns; Zoltán Benyó
Journal:  Front Med (Lausanne)       Date:  2022-01-20

Review 8.  The enzymology of the human prostanoid pathway.

Authors:  Roger Gregory Biringer
Journal:  Mol Biol Rep       Date:  2020-05-19       Impact factor: 2.316

9.  Isoform-Specific Compensation of Cyclooxygenase (Ptgs) Genes during Implantation and Late-Stage Pregnancy.

Authors:  Xinzhi Li; Laurel L Ballantyne; Mackenzie C Crawford; Garret A FitzGerald; Colin D Funk
Journal:  Sci Rep       Date:  2018-08-14       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.